This conference brings together scientists across the quickly growing field of microbiome engineering. The conference integrates synthetic biology, systems biology, microbial ecology, and bioinformati...

The role of type I interferon (IFN) in mediating tumor immunosurveillance, in situ vaccination, and response to other cancer immunotherapies is well established. The biologic and species-specific diff...

M. tuberculosis must survive within multiple macrophage populations during infection, including alveolar macrophages (AM) and recruited inflammatory macrophages. In mice, itaconate, produced in macrop...

Here, the authors profile bacterial engraftment in UC patients receiving FMT from a single donor and placebo samples to estimate noise, showing a significant level of false-positive engraftment, which...

Today thousands of health workers at the CDC and FDA lost their jobs—effective immediately.

U.S. national-security leaders included me in a group chat about upcoming military strikes in Yemen. I didn’t think it could be real. Then the bombs started falling.

YouTube video by Gustavo Dudamel

Here, the authors present a global meta-analysis of the human gut bacterium Ruminococcus gnavus, established an isolate collection with complete genomes and identified genetic features correlating wit...

Vedanta Biosciences, a late clinical-stage company developing defined bacterial consortia as oral therapies for gastrointestinal diseases, today annou

Donald Trump’s pick to lead the federal health agency has vowed to replace hundreds of staffers and shift research away from infectious diseases and vaccines. Such an overhaul could imperil the develo...

YouTube video by Jonathan Eisen

The development of fecal microbiota transplantation and defined live biotherapeutic products for the treatment of human disease has been an empirically driven process yielding a notable success of ...

Nature Medicine - Results of multi-omic profiling of the microbiome and host immunity of individuals treated with VE303 to prevent recurrent Clostridioides difficile infection in the context of a...

To the Editor—We congratulate Kelly et al on an excellent review of advances in microbiome therapeutic development [1]. The article states that the Food an

Urgent action underway to prevent dangerous microbes from spreading beyond country's borders

Strain richness of gut microbiota ecosystems is a key characteristic underpinning engraftment in faecal microbiota transplantation, and could improve the design of defined live biotherapeuti...

Dr. Scott Gottlieb, former FDA commissioner and CNBC contributor, joins 'Squawk Box' to discuss the incoming administration's picks for health cabinet positions, where Gottlieb's worries are, and much...

This exciting BBSRC-funded project aims to mechanistically characterise the fitness costs associated with vancomycin resistance in the Gram-positive opportunistic pathogens Enterococcus faecalis and E...

Please review the letter in full below. Sign on form HERE. ***Dear Members of the California Congressional Delegation:California is the epicenter of a public health threat that is stretching our healt...

YouTube video by Art Krieg

ASM Microbe 2025 showcases the best microbial sciences in the world and provides a one-of-a-kind forum to explore everything from basic microbiology to translation and application.

Bernat Olle, Ryan Ranallo, L Clifford McDonald; Correspondence to “Escape Velocity—the Launch of Microbiome Therapies“, The Journal of Infectious Diseases,